Product Name
EG-VEGF, Polyclonal Antibody
Full Product Name
Goat Anti-Human EG-VEGF
Product Synonym Names
PROK1; PK1; PRK1; EGVEGF
Product Gene Name
anti-EG-VEGF antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 1; NC_000001.11 (110451166..110457354). Location: 1p21
3D Structure
ModBase 3D Structure for P58294
Antibody Generation
Produced from sera of goats pre-immunized with highly pure (>98%) recombinant hEG-VEGF. Anti-hEG-VEGF specific antibody was purified by affinity chromatography employing immobilized hVEGF matrix.
ISO Certification
Manufactured in an ISO 9001:2008 Certified Laboratory.
Other Notes
Small volumes of anti-EG-VEGF antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-EG-VEGF antibody
Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits
biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways.
Applications Tested/Suitable for anti-EG-VEGF antibody
ELISA (EIA), Western Blot (WB)
NCBI/Uniprot data below describe general gene information for EG-VEGF. It may not necessarily be applicable to this product.
NCBI Accession #
NP_115790.1
[Other Products]
NCBI GenBank Nucleotide #
NM_032414.2
[Other Products]
UniProt Primary Accession #
P58294
[Other Products]
UniProt Secondary Accession #
Q5VWD4; Q8TC69[Other Products]
UniProt Related Accession #
P58294[Other Products]
Molecular Weight
11,715 Da
NCBI Official Full Name
prokineticin-1
NCBI Official Synonym Full Names
prokineticin 1
NCBI Official Symbol
PROK1 [Similar Products]
NCBI Official Synonym Symbols
PK1; PRK1; EGVEGF
[Similar Products]
NCBI Protein Information
prokineticin-1; EG-VEGF; mambakine; black mamba toxin-related protein; endocrine-gland-derived vascular endothelial growth factor
UniProt Protein Name
Prokineticin-1
UniProt Synonym Protein Names
Endocrine-gland-derived vascular endothelial growth factor; EG-VEGF; Mambakine
UniProt Gene Name
PROK1 [Similar Products]
UniProt Synonym Gene Names
EG-VEGF [Similar Products]
UniProt Entry Name
PROK1_HUMAN
NCBI Summary for EG-VEGF
The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. [provided by RefSeq, Sep 2011]
UniProt Comments for EG-VEGF
Function: Potently contracts gastrointestinal (GI) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types. Induces proliferation and differentiation, but not migration, of enteric neural crest cells. Directly influences neuroblastoma progression by promoting the proliferation and migration of neuroblastoma cells. Positively regulates PTGS2 expression and prostaglandin synthesis. May play a role in placentation. May play a role in normal and pathological testis angiogenesis. Ref.1 Ref.2 Ref.9 Ref.10 Ref.11
Subcellular location: Secreted.
Tissue specificity: Localizes to glandular epithelium, stroma and vascular epithelial cells of first trimester decidua (at protein level). Up-regulated in first trimester decidua when compared with non-pregnant endometrium. Expressed in the steroidogenic glands, ovary, testis, adrenal and placenta. Ref.2 Ref.9 Ref.11
Developmental stage: In ***** testis, is strongly expressed only in Leydig cells. In testicular tumors, expressed specifically in Leydig cell tumors (at protein level). Expressed from 14 weeks until birth in fetal testis.
Sequence similarities: Belongs to the AVIT (prokineticin) family.
Research Articles on EG-VEGF
1. EG-VEGF as a new placental growth factor acting during the first trimester of pregnancy, established its mechanism of action, and provide evidence for its deregulation in FGR.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.